DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Bäck M, Yin L, Ingelsson E.
Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib.
Eur Heart J 2012;
33: 1928-1933
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.